Literature DB >> 3307530

Hepatic circulation during surgical stress and anesthesia with halothane, isoflurane, or fentanyl.

S Gelman, E Dillard, E L Bradley.   

Abstract

Hepatic blood flow and the oxygen supply/uptake relation were studied in 19 miniature pigs using labeled microspheres. Changes in hepatic arterial blood flow and portal blood flow, as well as total hepatic blood flow during halothane anesthesia were more closely associated with changes in mean arterial pressure (MAP) and cardiac output than during anesthesia with isoflurane or fentanyl. Halothane or isoflurane administered in concentrations that decreased MAP by approximately 30% were accompanied by decreases in hepatic oxygen delivery (DO2th) averaging 46% during halothane and 31% during isoflurane anesthesia and parallel decreases in hepatic blood flow. In concentrations that decreased MAP by 50%, halothane and isoflurane decreased DO2th 61 and 37%, respectively. DO2th was maintained (statistically insignificant, 23% increase) during both doses of fentanyl administered (20 micrograms/kg followed by 0.17 microgram . kg-1 . min-1, and 50 micrograms/kg followed by 0.42 microgram . kg-1 . min-1). Hepatic oxygen uptake increased 50% during fentanyl and was maintained at baseline levels during both doses of halothane and isoflurane anesthesia. Oxygen content in hepatic venous blood was maintained at baseline levels during fentanyl and isoflurane administration and was decreased by both concentrations of halothane anesthesia. The hepatic oxygen supply demand ratio was maintained at baseline levels after both doses of fentanyl and during isoflurane administered in a concentration that decreased blood pressure 30%; the ratio decreased during isoflurane administered in a concentration decreasing blood pressure by 50% and during both doses of halothane anesthesia.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3307530

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  8 in total

1.  Retrospective study of post-anesthetic mild liver disorder associated with inhalation anesthetics, halothane and enflurane.

Authors:  Y Sakaguchi; S Inaba; Y Umeki; S Takahashi; J Yoshitake; Y Hayashi; K Akazawa; Y Nose
Journal:  J Anesth       Date:  1992-04       Impact factor: 2.078

Review 2.  [Central venous pressure in liver surgery : A primary therapeutic goal or a hemodynamic tessera?]

Authors:  C R Behem; M F Gräßler; C J C Trepte
Journal:  Anaesthesist       Date:  2018-10       Impact factor: 1.041

3.  [Influence of clonidine-induced systemic sympathicolysis on oxygenation and perfusion of the liver. Investigations with healthy pigs under general anesthesia].

Authors:  T Iber; J P Roesner; C Mutz; B Werner; E Peters; K Brüderlein; G Nöldge-Schomburg; D A Vagts
Journal:  Anaesthesist       Date:  2007-05       Impact factor: 1.041

4.  Anesthetic management of a patient with acute fatty liver of pregnancy.

Authors:  Naoyuki Fujimura; Tetsuo Omote; Naoto Inagaki; Johji Arakawa; Masatoshi Kotaki; Akiyoshi Namiki
Journal:  J Anesth       Date:  1998-09       Impact factor: 2.078

5.  Morphine pharmacokinetics and metabolism in humans. Enterohepatic cycling and relative contribution of metabolites to active opioid concentrations.

Authors:  J Hasselström; J Säwe
Journal:  Clin Pharmacokinet       Date:  1993-04       Impact factor: 6.447

6.  Supplemental oxygen does not reduce postoperative nausea and vomiting after thyroidectomy.

Authors:  J L Joris; N J Poth; A M Djamadar; D I Sessler; E E Hamoir; T R Defêchereux; M R Meurisse; M L Lamy
Journal:  Br J Anaesth       Date:  2003-12       Impact factor: 9.166

7.  An evaluation of hepatic extraction and clearance of doxorubicin.

Authors:  D A August; N Verma; M A Vaertan; R Shah; D E Brenner
Journal:  Br J Cancer       Date:  1995-07       Impact factor: 7.640

Review 8.  Anesthesia for patients with liver disease.

Authors:  Poupak Rahimzadeh; Saeid Safari; Seyed Hamid Reza Faiz; Seyed Moayed Alavian
Journal:  Hepat Mon       Date:  2014-07-01       Impact factor: 0.660

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.